Respiratory device maker Electromed Q1 revenue rises on higher growth in hospital, distributor markets

Reuters11-13
Respiratory device maker <a href="https://laohu8.com/S/ELMD">Electromed</a> Q1 revenue rises on higher growth in hospital, distributor markets

Overview

  • Electromed Q1 FY 2026 revenue grows 15.1% yr/yr to $16.9 mln

  • Net income rises 44.9% to $2.1 mln, reflecting strong operational execution

  • Company authorized $10 mln stock repurchase in Q1

Outlook

  • Electromed expects manufacturing optimization to support future growth

  • Company anticipates CRM system to boost sales productivity

  • Electromed aims for attractive returns in fiscal 2026 and beyond

Result Drivers

  • SALES TEAM EXPANSION - Increase in direct sales representatives and higher net revenues per representative drove revenue growth

  • HOSPITAL AND DISTRIBUTOR GROWTH - Significant revenue growth in hospital and distributor markets contributed to overall revenue increase

  • OPERATIONAL EFFICIENCIES - Improved efficiencies and new CRM system enhanced sales productivity and profitability

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

$16.9 mln

Q1 EPS

$0.25

Q1 Net Income

$2.1 mln

Q1 Operating Income

$2.7 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

  • Wall Street's median 12-month price target for Electromed Inc is $35.50, about 31.8% above its November 10 closing price of $24.20

Press Release: ID:nBw8lN4x1a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment